FindTrial
Sign In

Study to Assess the Benefit of LM Potency Homeopathic Medicines in Treating Eczema.

To study the effectiveness of LM potency in homeopathic management of Eczema. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104605
Enrollment
30
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

Intervention1: Individulised Homoeopathic Medicine: Individualized homoeopathic treatment will be administered using LM (50 millesimal) potency selected on the basis of totality of symptoms after deta

Sponsors

C D Pachchigar College of Homeopathic Medicine And Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age Groups: 0-65 years including both genders diagnosed with eczema

Exclusion criteria

Exclusion criteria: 1.Occupational contact dermatitis 2. Secondary skin infections 3. Alternative therapy during treatment like topical applications 4. If taking any medication like immunosuppressants/ corticosteroids.

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of LM potencies in reducing the intensity and frequency of eczema symptoms, measured by change in DLQI (Dermatology Life Quality Index) score from baseline to the end of treatment.Timepoint: 9 Months—

Secondary

MeasureTime frame
To evaluate the overall improvement in quality of life of eczema patients treated with LM potencies, assessed through DLQI score changes during follow-up.Timepoint: 9 Months—

Countries

India

Contacts

Public ContactMansi Jaysukhbhai Buha

C D Pachchigar College Of Homeopathic Medicine And Hospital

Drvismayp@gmail.com918347375491

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026